ONABOTULINUMTOXINA IN PATIENTS WITH OVERACTIVE BLADDER AND URINARY INCONTINENCE: CONSISTENT EFFECT OVER REPEAT TREATMENT

被引：2
|
作者：
Nitti, Victor W.
Sievert, Karl-Dietrich
Sussman, David
Radomski, Sidney B.
Sand, Peter
Thompson, Catherine
Nardo, Christopher
Zhou, Jihao
Globe, Denise
Haag-Molkenteller, Cornelia
Chapple, Christopher
机构：
来源：
JOURNAL OF UROLOGY | 2013年 / 189卷 / 04期
关键词：
D O I：
10.1016/j.juro.2013.02.2721
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1367
引用
收藏
页码：E559 / E560
页数：2
相关论文
共 50 条
  • [41] Behavioral Treatment of Urinary Incontinence, Voiding Dysfunction, and Overactive Bladder
    Burgio, Kathryn L.
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2009, 36 (03) : 475 - +
  • [42] LONG-TERM EFFICACY, SAFETY, AND QUALITY OF LIFE ANALYSIS OF REPEATED ONABOTULINUMTOXINA TREATMENT FOR PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER SYNDROME AND URINARY INCONTINENCE
    Salvatore, Stefano
    Chapple, Christopher
    Sussman, David
    Radomski, Sidney
    Sand, Peter
    Guard, Steven
    Zhou, Jihao
    Sievert, Karl Dietrich
    Nitti, Victor
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 : S1 - S2
  • [43] Early and Consistent Improvements in Urinary Symptoms and Quality of Life With OnabotulinumtoxinA in Patients With Overactive Bladder and Urinary Incontinence: Results From a Randomized, Placebo-controlled, Phase IV Clinical Trial
    McCammon, Kurt
    Gousse, Angelo
    Kohan, Alfred
    Glazier, David
    Gruenenfelder, Jennifer
    Bai, Zhanying
    Patel, Anand
    Hale, Douglass
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2021, 27 (07): : 450 - 456
  • [44] CONSISTENT AND DURABLE IMPROVEMENTS IN QUALITY OF LIFE WITH LONG-TERM ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH OVERACTIVE BLADDER.
    Tubaro, Andrea
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 : S59 - S60
  • [45] EARLY AND CONSISTENT IMPROVEMENTS IN URINARY SYMPTOMS AND QUALITY OF LIFE IN IDIOPATHIC OVERACTIVE BLADDER PATIENTS FOLLOWING REPEAT TREATMENT WITH ONABOTULINUMTOXINA: RESULTS OF A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 4 TRIAL
    McCammon, K.
    Gousse, A.
    Gruenenfelder, J.
    Hale, D.
    Orejudos, A.
    Patel, A.
    Kahan, A.
    NEUROUROLOGY AND URODYNAMICS, 2018, 37 : S395 - S396
  • [46] The treatment of overactive bladder syndrome with onabotulinumtoxinA therapy
    Majoros Attila
    Romics Miklos
    Ali Aida
    Hamvas Antal
    Molnar Peter Jozsef
    Keszthelyi Attila
    Nyirady Peter
    ORVOSI HETILAP, 2021, 162 (36) : 1459 - 1465
  • [47] DURABLE REDUCTIONS IN URINARY INCONTINENCE WITH LONG-TERM ONABOTULINUMTOXINA TREATMENT IN PATIENTS WITH OVERACTIVE BLADDER SYNDROME: FINAL RESULTS OF 3.5-YEAR STUDY
    Nitti, Victor
    De Ridder, Dirk
    Sussman, David
    Sand, Peter
    Sievert, Karl-Dietrich
    Chapple, Christopher
    Jenkins, Brenda
    Zheng, Yan
    Radomski, Sidney
    JOURNAL OF UROLOGY, 2015, 193 (04): : E719 - E720
  • [48] LONG-TERM EFFICACY AND SAFETY OF REPEAT ONABOTULINUMTOXINA TREATMENT IN OVERACTIVE BLADDER SYNDROME AND URINARY INCONTINENCE: THIRD INTERIM ANALYSIS, MEDIAN 2.4 YEAR FOLLOW-UP
    Nitti, Victor
    Chapple, Christopher
    Sussman, David
    Radomski, Sidney
    Sand, Peter
    Guard, Steven
    Nardo, Christopher
    Zhou, Jihao
    Sievert, Karl-Dietrich
    JOURNAL OF UROLOGY, 2014, 191 (04): : E400 - E401
  • [49] Real-world onabotulinumtoxinA treatment patterns in patients with overactive bladder
    Chughtai, Bilal
    Ricker, Christine N.
    Boldt, Ryan J.
    Elterman, Dean
    NEUROUROLOGY AND URODYNAMICS, 2024, 43 (02) : 396 - 406
  • [50] Socioeconomic burden of urinary incontinence with focus on overactive bladder and tolterodine treatment
    Luscombe, FA
    REVIEWS IN CONTEMPORARY PHARMACOTHERAPY, 2000, 11 (01): : 43 - 62
12345